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Objectives: Aim of this study was to describe the use of antithrombotic therapy in
Chinese patients with atrial ﬁbrillation (AF) and identify factors associated with
warfarin use at baseline and at 12-month follow-up.
Methods: Between November 2008 and October 2011, this prospective registry
enrolled patients presenting to an emergency department (ED) with AF at 20 sites in
China; 12-month follow-up was completed for all patients. Multivariate regression
models were used to determine predictors of warfarin use, respectively.
Results: Among 319 patients with valvular AF, 132 at baseline and 111 at follow-up
were on warfarin, while 43 (32.6%) and 64 (57.7%) have international normalized
ratio (INR) levels between 2.0 to 3.0, respectively. In patients with non-valvular AF
warfarin was most used in patients with CHADS2 scores¼1, and proportion of
patients met the target INR levels increased as rising of the CHADS2 score. Use of
aspirin also increased with risk score rising. Over half of low-risk patients received
antithrombotic drugs (60.2% and 55.3%, respectively). History of stroke/transient
ischemic attack (TIA) and prior diagnosis of AF were predictors for warfarin use at
baseline, as well as at follow-up, while there was a decreased likelihood of warfarin
use as increasing age, increasing heart rate (HR), and history of coronary artery
disease (CAD).
Conclusions: In China, antithrombotic therapy were overused in AF patients at low
risk of stroke and underused in high-risk patients. History of stroke/TIA, prior
diagnosis of AF, age, heart rate, and history of CAD were related with warfarin use.
GW25-e0716
Different inﬂuences of Single and Dual-chamber Pacing on Brachial Blood
Pressure, Central Aortic Pressure and Augmentation Index
Miao Shuai, Ye Lan, Yan Zhehui, Li Guangping
The second hospital of Tianjin Medical University
Objectives: To assess the different effects of cardiac pacing mode on brachial blood
pressure, central aortic pressure (CAP) and augmentation index.
Methods: 103 pacemaker-implanted patients were enrolled in this study in cohort.
The 103 patients were divided into three groups: single-chamber pacemaker group (41
cases), dual-chamber pacemaker group (42 cases). But the control group (20 cases)
enrolled pacemaker-implanted patients without pacing while examined. The brachial
systolic blood pressure (SBP1), brachial diastolic blood pressure (DBP1), pulse
pressure (PP), central aortic pressure (CAP), augmentation index (AI) were measured
in all enrolled subjects. And then DDD pacing mode of patients in dual-chamber
pacemaker group was programmed into VVI pacing mode and these parameters were
measured again.
Results: The values of SBP1, DBP1, PP, CAP and AI in control group were
138.622.43 mmHg, 74.3512.65 mmHg, 67.0523.17 mmHg, 138.7018.69
mmHg and 78.9513.31 respectively; Those in dual-chamber pacemaker group were
143.7919.39 mmHg, 73.2410.11 mmHg, 70.3317.81 mmHg, 149.6719.62
mmHg and 88.1910.29 respectively; those values in single-chamber pacemaker
group were 121.2319.84 mmHg, 65.6211.22 mmHg, 56.9218.12 mmHg,
124.3319.34 mmHg and 81.2612.28 respectively. The SBP1, DBP1 and PP in
dual-chamber pacing group were signiﬁcantly higher than single-chamber pacing
group (P<0.05). The CAP and AI in dual-chamber pacing group was signiﬁcantly
higher than the control group and single-chamber pacing group (P<0.05). The CAP in
control group were signiﬁcantly higher than VVI group (P<0.05).
Conclusions: Dual-chamber pacing could signiﬁcantly enhance patients’ brachial
blood pressure. Dual-chamber pacing may boost people’s CAP and AI, which could
be attributed to one of the adverse effects on cardiovascular events and long-term
prognosis in patient with right apex pacing.
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Objectives: To evaluate the beneﬁt of Home monitoring (HM) system in patients with
implantable cardioverter deﬁbrillator (ICD) or cardiac resynchronization therapy
deﬁbrillator (CRT-D).
Methods: Twenty-three patients undergoing implantation of ICD or CRT-D with HM
in our hospital were enrolled from January 2011 to August 2013. Data of patients were
transmitted by Home monitoring system. Data automatically collected on a daily basis
and alerts by HM were analyzed. Early detection and intervention effect of Home
monitoring system included arrhythmias or heart failure to clinical events and system
related events.JACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/CResults: The mean follow-up duration was 452.1262.2 days, a total of 1991 remote
transmissions were received. Among these transmissions, 1481 abnormal events were
reported and 96.4% of events were clinical-related, and 1.5% were system-related, no
transmissions by 2.1%. Most of the system-related events were abnormal sensing, and
one loose electrode placement of left ventricular was detected. Clinical events
included 84.7% arrhythmic events and 15.3% HF monitoring events. Alerts for HF
monitoring including heart rate at rest were increasing and CRT pacing percentage
was reduced. Through alerts of the HM, patients got physician advices by telephone in
65 times, parameters were optimized in 11 times, and treatment plan was adjusted in18
times, four patients were hospitalized again.
Conclusions: Home monitoring is necessary and safe method which could early
detect the abnormal events in the patients with ICD or CRT-D, This system is helpful
in making earlier clinical intervention, and optimizing follow-up management, it may
improve patients, quality of life and safety.
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Objectives: CHADS2 and CHA2DS2-VASc have been validated as predictors of
embolic risk, contributing to the optimization of antithrombotic prescribing practices
in heterogeneous atrial ﬁbrillation (AF) patients. However, independent validations
have reported conﬂicting results. This meta-analysis therefore aimed to compare the
diverse predictive values of these two methods for risk assessment in AF individuals
with and without anticoagulation therapy based on previous studies.
Methods: The data were systematically retrieved by searching the Cochrane Library,
PubMed and Embase databases reporting the diagnostic performance between
CHADS2 and CHA2DS2-VASc. In addition, we reviewed references, major textbooks,
and review articles. Pooled risk ratios were estimated by using a random-effects
model. Deﬁned endpoints were then compared between scores<2 and2, considering
the presence or absence of anticoagulation therapy.
Results: Twelve cohort studies were identiﬁed in the meta-analysis. With regard to the
occurrence of outcomes individually, patients with CHA2DS2-VASc scores2
showed a greater risk for stroke (RR 5.31, CI 3.69-7.62; P<0.00001) and thrombo-
embolism (RR 5.94, CI 5.48-6.43; P<0.00001) (pdiff¼0.55), regardless of the
presence or absence of anticoagulation therapy (RR 5.43, CI 4.92-6.00; P<0.00001
and RR 5.92, CI 5.26-6.67; P<0.00001, respectively) (pdiff¼0.57). A chi-squared test
to evaluate trends also conﬁrmed an increased risk of events in patients receiving
anticoagulants (both ptrend<0.001).
Conclusions: Our results showed better diagnostic performance for CHA2DS2-VASc
over CHADS2 for the distribution of greater numbers of patients and a greater inci-
dence of endpoints events into the high-risk stratiﬁcation, as well as the identiﬁcation
of patients with atrial ﬁbrillation who are at substantial risk of endpoint events with or
without optimal anticoagulant therapy.
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Objectives: By trying implanting a ventricular electrode through the coronary sinus
(CS) approach to achieve the conventional cardiac pacing, this study was designed to
overcome the potential risk of the traditional right ventricular endocardial pacing
through the tricuspid valve approach.
Methods: (1) 61 patients in line with ordinary cardiac pacing were continually
enrolled. All cases were randomly divided into the research group of CS ventricular
pacing and the traditional right ventricular pacing group. (2) For the research group,
ﬁrstly patients underwent a routine perfusion imaging through the CS approach or
accepted an insertion of a mapping electrode or conventional right ventricular elec-
trode to search for the CS port, then a dedicated left ventricular electrode through
a pushing sheath or a conventional right ventricular electrode was planted into a
corresponding targeted vein. For the traditional right ventricular pacing group, a
conventional right ventricular electrode was planted through the tricuspid valve
approach. (3) Indexes such as the X-ray exposure time of ventricular electrode
implantation, the success rate, the operation complications, the pacing parameters
were collected. (4) The SPSS 17.0 statistical software package was used for data
processing, and there was a signiﬁcant difference if P<0.05.
Results: (1) The success rate of the study group lower than the traditional right
ventricular pacing group (65.52% vs 100%, P¼0.001). In the study group the success
rate of CRT-dedicated left ventricular electrodes and delivery sheathes was higher
than that of conventional right ventricular electrodes (80.95% vs 25%, P¼0.009). (2)
There was no signiﬁcant difference of the severe pacing- related complications rate
(10.34% vs 0%, P¼0.203) between the two groups and the traditional group, and all
61 patients survived. (3) The X-ray exposure time of the study group was longer
(3.852.21 min vs 7.435.56 min, P¼0.01). (4) Tests during operation showed thatardiovascular Disease Clinical Research C157
